Home • Projects • Tesmilifene - Chemopotentiator for Cancer

An illustration of how multidrug resistant inhibitors (MDRIs) can block the p-glycoprotein (Pg) of resistant tumour cells and restore senstivity to cancer drugs. (Source: ABPI)

«Back	|	Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |